Effect of Histone Deacetylase Inhibitors on H3K4 Trimethylation in Mouse in vitro Models of Huntington's Disease
CSEF · 2012 Pharmacology/ Toxicology First Award
Overview
Objectives/Goals The project tested whether treatment of two different Huntington's Disease models with the HDAC inhibitors Trichostatin A and sodium butyrate would increase not only Histone 3 lysine 9 acetylation (H3K9Ac) but also H3K4 trimethylation (H3K4Me3) by causing transcriptional repression of the demethylase Jarid1C. Methods/Materials Cells from a mouse striatal cell line and primary cortical neurons were treated with TSA (25 or 100 nm) or NaB (.5 or 2 mM) for 24h or 48h. mRNA was extracted with the Quiagen kit and converted to cDNA. PCR was run using the SYBR Green method, with primers for Jarid1C, Jarid1B, or BDNF. For the western blot, cells were lysed and protein quantitated by the Lowry method. Protein was loaded onto the gel, and proteins were transferred to a nitrocellulose membrane. Primary antibodies were added first to H3K4Me3, and then to H3K9Ac. Secondary antibody conjugated to horse radish peroxidase was added, followed by color development. Results Treatment of striatal cells and primary cortical neurons resulted in an increase in both H3K9 acetylation and H3K4 trimethylation. In the primary cortical neurons, downregulation of brain-derived neurotrophic factor (BDNF) in HD-phenotype cells was rescued by 48h treatment with NaB. The demethylase Jarid1C did not show a decrease upon treatment in either model. Conclusions/Discussion As hypothesized, treatment with the HDAC inhibitors increased both H3K9 acetylation and H3K4 trimethylation. However, the increase in methylation was not caused by downregulation of the demethylase Jarid1C. Overall, this study supports the idea that HDAC inhibitors restore aberrant transcription in HD by increasing both acetylation and methylation, although more work must be done to fully understand the cross-talk between these two chromatin marks.
Summary statement
This project is meant to study the effect of two histone deacetylase inhibitors on H3K4 trimethylation in Huntington's Disease.
Help received
Used lab equipment at Dr. Leslie Thompson's lab at the University of California, Irvine under the supervision of Mrs. Alice Lau
Awards (1)
Competition history
- CSEF 2012
Resources
Related projects
CSEF · 2008
The Role of Histone Modifications in Transcriptional Dysregulation of Neuronal Genes in Huntington's Disease
ISEF · 2014
Moving Towards the Cure for Alzheimer's Disease: The Effects of Histone Deacetylase Inhibitors on Neurofibrillary Tangle Formation and Microtubule Stability to Preserve Neuronal Integrity (A Novel in vitro Trial)
CSEF · 2005
Discovery of Novel Histone Deacetylase Inhibitors for Breast Cancer
ISEF · 2019
Examining the Role of Transcription Factors, Nr4a1, Foxp1, and Olig2, in the Development of Medium Spiny Neurons from the Q175 Mouse Model of Huntington's Disease
ISEF · 2015
Identification of Therapeutic Compounds for Treating Huntington’s Disease: High Content Screening of Small Molecules for Modulating N17 Phosphorylation of Mutant Huntingtin
ISEF · 2015
Investigation of Autophagy in Huntington's Disease using a Mutant Huntingtin Knock-in Striatal Cell Line
JSHS · 2024
Design, Facile Synthesis, and Evaluation of a Chalcone-Based Small Molecule ULK1 Agonist for the Treatment of Huntington’s Disease
CSEF · 2018
A Precision Medicine Approach: Epigenetic Inhibitors Induce Highly-Specific Apoptosis in High Risk Acute Leukemia
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects